![PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts113/v4/12/35/a6/1235a6f7-320a-db51-94c0-bbcbcd171dd6/mza_3933038130939089111.jpg/100x100bb.jpg)
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS - Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast
English - July 22, 2021 23:00 - 57 minutes - ★★★ - 4 ratingsScience cme medical education cme credits peerview insession inreview endocrinology diabetes cne Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Go online to PeerView.com/FQJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, which is based on a recent live web broadcast, two obesity experts discuss weight-loss pharmacotherapy in the context of bariatric surgery as part of practical, case-centered sessions, designed to mimic the treatment considerations faced in real-world practice and illustrate how incretin-based agents can be used to individualize long-term obesity management and improve patient outcomes. Upon completion of this accredited CE activity, participants should be better able to: Recognize the roles of treatment options used adjunct to lifestyle interventions, particularly weight-loss pharmacotherapy and surgery, in addressing obesity pathophysiology, including metabolic adaptation, Assess the available evidence on current and emerging options in incretin-based weight-loss pharmacotherapies, including long-term efficacy and safety data, Integrate incretin-based pharmacotherapy into individualized, evidence-based treatment plans for long-term obesity management.